This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights Rigetti Computing and IonQ
by Zacks Equity Research
Rigetti and IonQ are advancing along different quantum paths, superconducting chiplets vs. trapped ions, but Zacks sees Rigetti as the slightly stronger near-term bet.
Rigetti vs IonQ: Which Quantum Computing Stock Is the Smarter Buy?
by Harshit Gupta
RGTI's superconducting roadmap and IONQ's trapped-ion expansion highlight two sharply different bets in quantum computing's race to scale.
Can Rigetti Computing's Margin Recover After Second-Quarter Pressure?
by Zacks Equity Research
RGTI's second-quarter results show shrinking revenues and margins, even as its new Cepheus-1-36Q quantum system hit key milestones.
The Zacks Analyst Blog Highlights Quantum Computing, IonQ, Rigetti Computing, D-Wave Quantum and NVIDIA
by Zacks Equity Research
Quantum Computing Inc. soars over 2000%, sparking comparisons to NVIDIA, but its small revenue base makes the stock a high-risk bet.
Can QUBT Become the Next NVIDIA, and Should You Buy the Stock?
by Tirthankar Chakraborty
QCi shares surged over 2000% as its photonic quantum push, NASA ties, and Arizona chip foundry fuel investor attention.
IonQ or Rigetti: Who Wins From Microsoft's Cloud Quantum Push?
by Urmimala Biswas
RGTI's chiplet tech, Azure integration, and solid financials put it ahead of IONQ as Microsoft fuels quantum's cloud future.
IonQ, Inc. (IONQ) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
IonQ (IONQ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Short-Term Pain, Long-Term Gain? 4 Quantum Stocks to Watch
by Urmimala Biswas
IonQ, D-Wave, Rigetti and QUBT report steep Q2 losses but strengthen cash positions with major fundraising to fuel quantum growth.
Big Tech Woes Power Surge in Inverse Single-Stock ETFs
by Sweta Killa
PLTZ, SMST, IONZ, CONI and SMCZ witness double-digit gains as the S&P 500 logged its longest losing streak of 2025 on tech-driven weakness.
QUBT Is Cash Rich but Its Revenues Are Poor: How to Play the Stock
by Urmimala Biswas
Quantum Computing boasts strong cash reserves and key partnerships, but widening losses and weak revenues keep investors cautious.
The Zacks Analyst Blog Highlights IonQ, Microsoft, Amazon.com, Alphabet and NVIDIA
by Zacks Equity Research
IONQ's 457.9% surge, bold acquisitions, and cloud integrations fuel its bid to become the NVIDIA of quantum computing, but profitability remains elusive.
Can IONQ Become the NVIDIA of Quantum Computing, and Is It a Buy?
by Tirthankar Chakraborty
IonQ's soaring revenues, acquisitions and cloud integrations fuel bold ambitions, but steep losses raise questions about its NVIDIA-like aspirations.
QBTS Secures $819M Cash War Chest for Future R&D: Upside Ahead?
by Urmimala Biswas
QBTS builds a record $819M cash pile to fuel R&D, expand globally and pursue acquisitions, with analysts eyeing near-term upside.
IonQ Advances Millions-Qubit Roadmap but is the Stock Overpriced?
by Urmimala Biswas
IonQ's bold acquisitions and quantum roadmap aim at millions of qubits, but its lofty valuation raises questions for investors.
QUBT Expands Verticals From Aerospace to Cybersecurity: Stock to Gain?
by Urmimala Biswas
QUBT's technology is gaining traction across aerospace, automotive and cybersecurity, fueling adoption despite financial hurdles.
The Zacks Analyst Blog Highlights D-Wave Quantum, Rigetti Computing, IonQ, AstraZeneca, AWS and NVIDIA
by Zacks Equity Research
D-Wave, IonQ, and Rigetti post rising revenues, steep losses, and big cash reserves as they race to build scalable quantum systems.
Quantum Stocks Q2 2025: Are D-Wave, IonQ & Rigetti Funding the Future?
by Urmimala Biswas
D-Wave, IonQ and Rigetti post strong Q2 sales, incur steeper losses and have billion-dollar cash reserves to drive quantum breakthroughs.
QBTS Stock Jumps After Q2 But Profit Woes Cloud Outlook: Time to Sell?
by Urmimala Biswas
QBTS surges on Q2 revenue growth and big-name clients but steep losses and a rich valuation may test investor patience.
Zacks Investment Ideas feature highlights: IonQ, Hims and Hers, Eli Lilly and TransMedics
by Zacks Equity Research
Insider moves in IonQ, Hims and Hers, Eli Lilly, and TransMedics reveal bold buys, record sales, and signals worth watching.
3 Unusual Insider Transactions you Should Know About
by Andrew Rocco
While no single indicator can guarantee a stock's performance, the pattern of insider transactions can provide a powerful glimpse into a company's prospects.
BBAI Stock Tumbles on Q2 Loss, Revenues Decline Y/Y, '25 View Down
by Zacks Equity Research
BigBear.ai shares plunge 31.2% as Q2 revenues drop 18% Y/Y and the 2025 sales outlook is cut on Army program weakness.
Can Rigetti's Chiplet Strategy Secure Its Spot in DARPA's Next Phase?
by Harshit Gupta
RGTI is betting on chiplet-based quantum systems to meet DARPA's benchmarks and secure a spot in its next program phase.
IonQ, Inc. (IONQ) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
IonQ (IONQ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Rigetti Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
by Harshit Gupta
RGTI is likely to report Q2 results with tech gains in its 36-qubit system, but revenue growth hinges on wider customer adoption.
IonQ Stock Surges on Quantum Breakthroughs: More Upside Ahead?
by Urmimala Biswas
IonQ secures major global partnerships and delivers quantum breakthroughs, driving 27% stock gains in three months.